STONKWHISPER
← Back to Intel
Insider ActivitySYRE

Sloan Sheldon, Chief Medical Officer at Spyre Therapeutics, Inc., sold $377K of SYRE

Updated Jun 14, 2026
Sloan Sheldon Chief Medical Officer
Spyre Therapeutics, Inc. · $SYRE
$377K Total Value
5,059 Shares Traded
$74.6 Price / Share
400 Shares Owned After
2026-05-01 Filing Date

Transaction Details

InsiderSloan Sheldon
TitleChief Medical Officer
CompanySpyre Therapeutics, Inc.
TickerSYRE
Transaction TypeSale
Transaction Date2026-05-01
Shares Traded5,059
Price Per Share$74.6
Total Value$377K
Filed Date2026-05-01
Accession Number0002038798-26-000004

Ownership Context

Shares Owned After Transaction400
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0002038798-26-000004

Other Insider Trades — SYRE

InsiderTitleActionValueDate
Sloan SheldonChief Medical Officertraded$229K2026-06-03
Sloan SheldonChief Medical Officersold$625K2026-06-03
Burrows Scott LChief Financial Officersold$223K2026-06-01
Turtle CameronChief Executive Officer, Directorsold$235K2026-06-01
Burrows Scott LChief Financial Officersold$126K2026-06-01
Burrows Scott LChief Financial Officersold$184K2026-06-01
Turtle CameronChief Executive Officer, Directorsold$247K2026-06-01
Turtle CameronChief Executive Officer, Directorsold$575K2026-06-01
Burrows Scott LChief Financial Officertraded$109K2026-06-01
HENDERSON MICHAEL THOMASDirectortraded—2026-05-27

Other Trades by Sloan Sheldon

TickerCompanyActionValueDate
SYRESpyre Therapeutics, Inc.traded$229K2026-06-03
SYRESpyre Therapeutics, Inc.sold$625K2026-06-03
SYRESpyre Therapeutics, Inc.sold$1.5M2026-05-01
SYRESpyre Therapeutics, Inc.sold$1.4M2026-05-01
SYRESpyre Therapeutics, Inc.sold$932K2026-05-01
SYRESpyre Therapeutics, Inc.sold$764K2026-05-01
SYRESpyre Therapeutics, Inc.sold$30K2026-05-01
SYRESpyre Therapeutics, Inc.sold$628K2026-05-01
SYRESpyre Therapeutics, Inc.traded$2.2M2026-05-01
SYRESpyre Therapeutics, Inc.traded$172K2026-04-01

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for SYRE — Spyre Therapeutics, Inc. →

Track SYRE insider activity in real time on The Wire →

Get alerts when Sloan Sheldon files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 14, 2026 at 07:14 UTC

Want real-time data? Access The Wire for live sentiment tracking.

Share:TwitterRedditLinkedIn